DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/b242ee77/bronchitis_pipel) has announced the addition of Global Markets Direct's new report "Bronchitis - Pipeline Review, H1 2012" to their offering.
Global Markets Direct's, 'Bronchitis - Pipeline Review, H1 2012', provides an overview of the Bronchitis therapeutic pipeline. This report provides information on the therapeutic development for Bronchitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bronchitis. 'Bronchitis - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Key Topics Covered:
- Introduction
- Global Markets Direct Report Coverage
- Bronchitis Overview
- Therapeutics Development
- An Overview of Pipeline Products for Bronchitis
- Bronchitis Therapeutics under Development by Companies
- Bronchitis Therapeutics under Investigation by Universities/Institutes
- Late Stage Products
- Comparative Analysis
- Mid Clinical Stage Products
- Comparative Analysis
- Early Clinical Stage Products
- Comparative Analysis
- Pre-Clinical Stage Products
- Comparative Analysis
- Bronchitis Therapeutics - Products under Development by Companies
- Bronchitis Therapeutics - Products under Investigation by Universities/Institutes
- Companies Involved in Bronchitis Therapeutics Development
- Bronchitis - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Drug Profiles
- Bronchitis Therapeutics - Drug Profile Updates
- Bronchitis Therapeutics - Discontinued Products
- Bronchitis Therapeutics - Dormant Products
- Bronchitis - Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
Companies Mentioned:
- Rib-X Pharmaceuticals, Inc.
- PARI Pharma GmbH
- Cytokinetics, Inc
- Yuhan Corporation
- Ahn-Gook Pharmaceutical Co., Ltd.
- SCOLR Pharma, Inc.
- NanoBio Corporation
- iNova Pharmaceuticals (Australia) Pty Limited
- Beech Tree Labs, Inc.
For more information visit http://www.researchandmarkets.com/research/b242ee77/bronchitis_pipel
Source: Global Markets Direct